Patients with active IBD present with reduced serum levels of insulin-like growth factor I (IGF-I) [4, 5], likely secondary to a combination of GH resistance, gastrointestinal dysfunction, and chronic inflammation [3, 6, 7]. The gene discussed is IGF1; the disease is inflammatory bowel disease.